Welcome to our dedicated page for TRAVELERS COMPANIES SEC filings (Ticker: TRV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TRAVELERS COMPANIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TRAVELERS COMPANIES's regulatory disclosures and financial reporting.
Travelers Companies (TRV) filed a notice of proposed sale of 6,000 shares of common stock through Fidelity Brokerage Services LLC on July 21, 2026, to be delivered via stock option exercise for cash. The issuer is listed as the source of the shares. The filing also reports that 10,000 common shares were sold on May 26, 2026 for approximately $3,076,546.00 by Michael F. Klein.
The Travelers Companies, Inc. plans an offering of senior unsecured notes due 2031 under its shelf registration. The notes will pay fixed interest semi-annually beginning in 2027 and will be issued in $2,000 minimum denominations, in book-entry form through DTC, Clearstream and Euroclear.
Prior to a Par Call Date one month before maturity, the notes are redeemable at a make-whole redemption price based on a defined Treasury Rate; on or after that date they are redeemable at 100% of principal plus accrued interest. The notes rank equally with all other senior unsecured debt and are structurally subordinated to obligations of subsidiaries.
Travelers estimates it will receive net proceeds (after underwriting discounts and expenses) for general corporate purposes. As of June 30, 2026, consolidated debt and equity data are provided to show capitalization before and after the issuance. The underwriting syndicate is led by major investment banks, which may stabilize trading and make a market in the notes.
The Travelers Companies, Inc. reported strong profitability for the quarter ended June 30, 2026. Net income was $2.21 billion, up from $1.51 billion a year earlier, and diluted EPS rose to $10.26 from $6.53, helped by share repurchases. The combined ratio improved to 83.6% from 90.3%, reflecting lower catastrophe losses of $518 million versus $927 million, higher net favorable prior year reserve development of $578 million versus $315 million, and stronger underlying underwriting margins.
For the first six months of 2026, net income increased to $3.92 billion from $1.90 billion and diluted EPS to $18.01 from $8.23, while the combined ratio improved to 86.1% from 96.3%. Catastrophe losses fell to $1.28 billion from $3.19 billion, and net favorable prior year reserve development rose to $991 million. Net investment income grew to $1.07 billion in the quarter with a 4.0% average pre-tax yield. Travelers ended the quarter with $103.18 billion of investments, total assets of $143.58 billion, shareholders’ equity of $33.12 billion, a debt-to-total capital ratio of 21.5%, book value per share of $158.81, and holding company liquidity of $2.51 billion. Capital returned to shareholders in the quarter totaled $1.58 billion, including $1.31 billion of repurchases and $266 million of dividends, while earned premiums decreased 2% to $10.75 billion, partly because 2025 included premiums from Canadian operations sold on January 2, 2026.
The Travelers Companies, Inc. reported very strong second quarter 2026 results, with net income of $2.208 billion and diluted EPS of $10.26, up from $1.509 billion and $6.53 a year earlier. Core income was $2.160 billion, or $10.04 per diluted share. The consolidated combined ratio improved to 83.6% from 90.3%, while catastrophe losses fell to $518 million pre-tax from $927 million and net favorable prior year reserve development rose to $578 million pre-tax. After-tax net investment income increased 14% to $883 million. Return on equity reached 27.1% and core return on equity 24.9%.
Net written premiums for the quarter were $11.529 billion, comparable with the prior year quarter, with growth in Business Insurance and Bond & Specialty Insurance and lower Personal Insurance premiums, as well as the effect of the Canadian divestiture. Underlying underwriting income was $1.678 billion pre-tax and the underlying combined ratio was 84.1%. Shareholders’ equity was $33.121 billion at June 30, 2026; book value per share rose to $158.81 and adjusted book value per share to $168.20. During the quarter the company returned $1.577 billion of capital to shareholders, including $1.311 billion of share repurchases, and declared a quarterly dividend of $1.25 per share.
Travelers Companies director Elizabeth Robinson received a grant of 132.53 deferred common stock units on June 30, 2026, in lieu of cash fees under the company’s Deferred Compensation Plan for Non-Employee Directors. Each unit will convert into one share of common stock upon distribution. After this award and additional units credited through dividend reinvestment, she holds a total of 12,561.986 deferred common stock units.
Travelers Companies director Russell G. Golden reported an award of 140.1 deferred common stock units on Company stock. These units were granted in lieu of cash compensation under the Deferred Compensation Plan for Non-Employee Directors at a reference value of $330.12 per share. The award increases his direct deferred unit holdings to 5,599.757, which also include 20.595 units acquired on June 30, 2026 through the plans’ dividend reinvestment features. The deferred units will convert into the same number of Travelers common shares upon distribution, which can occur in a lump sum or annual installments at the director’s election.
TRAVELERS COMPANIES, INC. executive Michael Frederick Klein, EVP & President, Personal Insurance, reported a mix of option exercise and share sales in Common Stock. He exercised 10,000 stock options at a price of $132.58 per share, converting them into an equal number of common shares.
On the same date, he completed open-market sales totaling 10,000 shares of Common Stock across three transactions: 1,519 shares at a weighted average of $308.792, 2,412 shares at $308.333, and 6,069 shares at $307.1003. After these transactions, he directly holds 49,055.787 shares of Common Stock and indirectly holds 1,888.345 shares through a 401(k) Plan.
Footnotes state that the sale prices are weighted averages over stated price ranges, and full price breakdowns are available upon request to the company or regulators.
Travelers Companies EVP and Chief Admin Officer Andy F. Bessette reported an option exercise and related share sale. On May 22, 2026, he exercised stock options to acquire 4,255 shares of common stock at $189.01 per share, then sold 4,255 shares in an open-market transaction at $308.11 per share.
After these transactions, Bessette directly held 24,284.397 shares of Travelers common stock and indirectly held 1,714.863 shares through a 401(k) Plan. No remaining derivative position is shown for the exercised options.
TRV Rule 144 notice reports planned and recent transactions in Common Stock by a broker and an individual. The filing lists 10,000 shares designated for sale on 05/26/2026 and shows a prior sale of 10,000 shares on 04/20/2026. The entries include aggregate dollar figures associated with each line.
The Travelers Companies, Inc. reported results from its annual shareholder meeting and an update to its equity compensation plan. Shareholders approved an amendment to the 2023 Stock Incentive Plan that increases the number of shares authorized for issuance by 5,000,000 shares.
All director nominees were elected, and shareholders ratified the company’s independent registered public accounting firm. They also approved, on a non-binding basis, the executive compensation program. Shareholder proposals on climate-related pricing and coverage reporting and on appointing an independent board chair did not receive enough support to pass.